UBS Group
SLSN

UBS Group’s Solesence Inc SLSN Stock Holding History

UBS Group’s Portfolio SLSN Stock Details SLSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54 Sell
74
-12,744
-99% -$15.7K ﹤0.01% 10185
2026
Q1 		$12.2K Sell
12,818
-3,620
-22% -$4.58K ﹤0.01% 8266
2025
Q4 		$26.2K Sell
16,438
-2,612
-14% -$7.08K ﹤0.01% 7602
2025
Q3 		$61.3K Buy
19,050
+6,811
+56% +$24.4K ﹤0.01% 7424
2025
Q2 		$53.4K Buy
+12,239
New +$43K ﹤0.01% 7714

Other funds holding SLSN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.5B AUM 28.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group's SLSN Position: Q2 2026 in Review

UBS Group reduced its Solesence Inc (SLSN) stake by 99% in Q2 2026, selling an estimated $15.7K and leaving 74 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #10185.

UBS Group first reported a position in SLSN in Q2 2025 and has held it in 5 quarters since. The position peaked at $61.3K in Q3 2025. 44 funds tracked by Wall St. Rank hold SLSN as of Q2 2026.

  • UBS Group held 74 shares of Solesence Inc worth $54 as of Q2 2026.
  • UBS Group sold 12,744 Solesence Inc shares in Q2 2026, an estimated $15.7K.
  • Solesence Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10185 holding.
  • UBS Group first reported a position in Solesence Inc in Q2 2025 and has held it in 5 quarters since.
  • UBS Group's Solesence Inc position peaked at $61.3K in Q3 2025.
  • 44 funds tracked by Wall St. Rank held Solesence Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.